Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
In Reply to Hannoun-Levi et al.
Rahimi A, Simmons A, Kim DN, Leitch M, Haas J, Gu X, Ahn C, Gao A, Spangler A, Morgan HE, Goudreau S, Seiler S, Farr D, Wooldridge R, Haley B, Bahrami S, Neufeld S, Mendez C, Alluri P, Rao R, Timmerman RD. Rahimi A, et al. Among authors: wooldridge r. Int J Radiat Oncol Biol Phys. 2022 Jun 1;113(2):475-477. doi: 10.1016/j.ijrobp.2022.02.034. Int J Radiat Oncol Biol Phys. 2022. PMID: 35569485 No abstract available.
Aspirin/antiplatelet agent use improves disease-free survival and reduces the risk of distant metastases in Stage II and III triple-negative breast cancer patients.
Shiao J, Thomas KM, Rahimi AS, Rao R, Yan J, Xie XJ, DaSilva M, Spangler A, Leitch M, Wooldridge R, Rivers A, Farr D, Haley B, Kim DW. Shiao J, et al. Among authors: wooldridge r. Breast Cancer Res Treat. 2017 Feb;161(3):463-471. doi: 10.1007/s10549-016-4081-8. Epub 2016 Dec 22. Breast Cancer Res Treat. 2017. PMID: 28005245
Preliminary Results of a Phase 1 Dose-Escalation Trial for Early-Stage Breast Cancer Using 5-Fraction Stereotactic Body Radiation Therapy for Partial-Breast Irradiation.
Rahimi A, Thomas K, Spangler A, Rao R, Leitch M, Wooldridge R, Rivers A, Seiler S, Albuquerque K, Stevenson S, Goudreau S, Garwood D, Haley B, Euhus D, Heinzerling J, Ding C, Gao A, Ahn C, Timmerman R. Rahimi A, et al. Among authors: wooldridge r. Int J Radiat Oncol Biol Phys. 2017 May 1;98(1):196-205.e2. doi: 10.1016/j.ijrobp.2017.01.020. Epub 2017 Jan 12. Int J Radiat Oncol Biol Phys. 2017. PMID: 28586960 Free article. Clinical Trial.
Novel hyaluronan formulation for preventing acute skin reactions in breast during radiotherapy: a randomized clinical trial.
Rahimi A, Mohamad O, Albuquerque K, Kim DWN, Chen D, Thomas K, Wooldridge R, Rivers A, Leitch M, Rao R, Haley B, Ahn C, Garwood D, Spangler A. Rahimi A, et al. Among authors: wooldridge r. Support Care Cancer. 2020 Mar;28(3):1481-1489. doi: 10.1007/s00520-019-04957-0. Epub 2019 Jul 4. Support Care Cancer. 2020. PMID: 31273506 Clinical Trial.
Risk Factors for Fat Necrosis After Stereotactic Partial Breast Irradiation for Early-Stage Breast Cancer in a Phase 1 Clinical Trial.
Rahimi A, Zhang Y, Kim DW, Morgan H, Hossain F, Leitch M, Wooldridge R, Seiler S, Goudreau S, Haley B, Rao R, Rivers A, Spangler A, Ahn C, Stevenson S, Staley J, Albuquerque K, Ding C, Gu X, Zhao B, Timmerman R. Rahimi A, et al. Among authors: wooldridge r. Int J Radiat Oncol Biol Phys. 2020 Nov 1;108(3):697-706. doi: 10.1016/j.ijrobp.2020.05.025. Epub 2020 May 26. Int J Radiat Oncol Biol Phys. 2020. PMID: 32464155 Clinical Trial.
33 results